PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death

E. M. Schweikert, A. Devarajan, I. Witte, P. Wilgenbus, J. Amort, U. Förstermann, A. Shabazian, V. Grijalva, D. M. Shih, R. Farias-Eisner, J. F. Teiber, S. T. Reddy, S. Horke

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

To achieve malignancy, cancer cells convert numerous signaling pathways, with evasion from cell death being a characteristic hallmark. The cell death machinery represents an anti-cancer target demanding constant identification of tumor-specific signaling molecules. Control of mitochondrial radical formation, particularly superoxide interconnects cell death signals with appropriate mechanistic execution. Superoxide is potentially damaging, but also triggers mitochondrial cytochrome c release. While paraoxonase (PON) enzymes are known to protect against cardiovascular diseases, recent data revealed that PON2 attenuated mitochondrial radical formation and execution of cell death. Another family member, PON3, is poorly investigated. Using various cell culture systems and knockout mice, here we addressed its potential role in cancer. PON3 is found overexpressed in various human tumors and diminishes mitochondrial superoxide formation. It directly interacts with coenzyme Q10 and presumably acts by sequestering ubisemiquinone, leading to enhanced cell death resistance. Localized to the endoplasmic reticulum (ER) and mitochondria, PON3 abrogates apoptosis in response to DNA damage or intrinsic but not extrinsic stimulation. Moreover, PON3 impaired ER stress-induced apoptotic MAPK signaling and CHOP induction. Therefore, our study reveals the mechanism underlying PON3's anti-oxidative effect and demonstrates a previously unanticipated function in tumor cell development. We suggest PONs represent a novel class of enzymes crucially controlling mitochondrial radical generation and cell death.

Original languageEnglish (US)
Pages (from-to)1549-1560
Number of pages12
JournalCell Death and Differentiation
Volume19
Issue number9
DOIs
StatePublished - Sep 2012

Fingerprint

Superoxides
Cell Death
coenzyme Q10
Neoplasms
Aryldialkylphosphatase
Endoplasmic Reticulum Stress
Enzymes
Cytochromes c
Knockout Mice
Endoplasmic Reticulum
DNA Damage
Mitochondria
Cardiovascular Diseases
Cell Culture Techniques
Apoptosis

Keywords

  • apoptosis
  • cancer
  • endoplasmic reticulum stress
  • mitochondria
  • oxidative stress
  • paraoxonase

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Schweikert, E. M., Devarajan, A., Witte, I., Wilgenbus, P., Amort, J., Förstermann, U., ... Horke, S. (2012). PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death. Cell Death and Differentiation, 19(9), 1549-1560. https://doi.org/10.1038/cdd.2012.35

PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death. / Schweikert, E. M.; Devarajan, A.; Witte, I.; Wilgenbus, P.; Amort, J.; Förstermann, U.; Shabazian, A.; Grijalva, V.; Shih, D. M.; Farias-Eisner, R.; Teiber, J. F.; Reddy, S. T.; Horke, S.

In: Cell Death and Differentiation, Vol. 19, No. 9, 09.2012, p. 1549-1560.

Research output: Contribution to journalArticle

Schweikert, EM, Devarajan, A, Witte, I, Wilgenbus, P, Amort, J, Förstermann, U, Shabazian, A, Grijalva, V, Shih, DM, Farias-Eisner, R, Teiber, JF, Reddy, ST & Horke, S 2012, 'PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death', Cell Death and Differentiation, vol. 19, no. 9, pp. 1549-1560. https://doi.org/10.1038/cdd.2012.35
Schweikert, E. M. ; Devarajan, A. ; Witte, I. ; Wilgenbus, P. ; Amort, J. ; Förstermann, U. ; Shabazian, A. ; Grijalva, V. ; Shih, D. M. ; Farias-Eisner, R. ; Teiber, J. F. ; Reddy, S. T. ; Horke, S. / PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death. In: Cell Death and Differentiation. 2012 ; Vol. 19, No. 9. pp. 1549-1560.
@article{12c7c452771e41e5b85d9eb56acc3944,
title = "PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death",
abstract = "To achieve malignancy, cancer cells convert numerous signaling pathways, with evasion from cell death being a characteristic hallmark. The cell death machinery represents an anti-cancer target demanding constant identification of tumor-specific signaling molecules. Control of mitochondrial radical formation, particularly superoxide interconnects cell death signals with appropriate mechanistic execution. Superoxide is potentially damaging, but also triggers mitochondrial cytochrome c release. While paraoxonase (PON) enzymes are known to protect against cardiovascular diseases, recent data revealed that PON2 attenuated mitochondrial radical formation and execution of cell death. Another family member, PON3, is poorly investigated. Using various cell culture systems and knockout mice, here we addressed its potential role in cancer. PON3 is found overexpressed in various human tumors and diminishes mitochondrial superoxide formation. It directly interacts with coenzyme Q10 and presumably acts by sequestering ubisemiquinone, leading to enhanced cell death resistance. Localized to the endoplasmic reticulum (ER) and mitochondria, PON3 abrogates apoptosis in response to DNA damage or intrinsic but not extrinsic stimulation. Moreover, PON3 impaired ER stress-induced apoptotic MAPK signaling and CHOP induction. Therefore, our study reveals the mechanism underlying PON3's anti-oxidative effect and demonstrates a previously unanticipated function in tumor cell development. We suggest PONs represent a novel class of enzymes crucially controlling mitochondrial radical generation and cell death.",
keywords = "apoptosis, cancer, endoplasmic reticulum stress, mitochondria, oxidative stress, paraoxonase",
author = "Schweikert, {E. M.} and A. Devarajan and I. Witte and P. Wilgenbus and J. Amort and U. F{\"o}rstermann and A. Shabazian and V. Grijalva and Shih, {D. M.} and R. Farias-Eisner and Teiber, {J. F.} and Reddy, {S. T.} and S. Horke",
year = "2012",
month = "9",
doi = "10.1038/cdd.2012.35",
language = "English (US)",
volume = "19",
pages = "1549--1560",
journal = "Cell Death and Differentiation",
issn = "1350-9047",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death

AU - Schweikert, E. M.

AU - Devarajan, A.

AU - Witte, I.

AU - Wilgenbus, P.

AU - Amort, J.

AU - Förstermann, U.

AU - Shabazian, A.

AU - Grijalva, V.

AU - Shih, D. M.

AU - Farias-Eisner, R.

AU - Teiber, J. F.

AU - Reddy, S. T.

AU - Horke, S.

PY - 2012/9

Y1 - 2012/9

N2 - To achieve malignancy, cancer cells convert numerous signaling pathways, with evasion from cell death being a characteristic hallmark. The cell death machinery represents an anti-cancer target demanding constant identification of tumor-specific signaling molecules. Control of mitochondrial radical formation, particularly superoxide interconnects cell death signals with appropriate mechanistic execution. Superoxide is potentially damaging, but also triggers mitochondrial cytochrome c release. While paraoxonase (PON) enzymes are known to protect against cardiovascular diseases, recent data revealed that PON2 attenuated mitochondrial radical formation and execution of cell death. Another family member, PON3, is poorly investigated. Using various cell culture systems and knockout mice, here we addressed its potential role in cancer. PON3 is found overexpressed in various human tumors and diminishes mitochondrial superoxide formation. It directly interacts with coenzyme Q10 and presumably acts by sequestering ubisemiquinone, leading to enhanced cell death resistance. Localized to the endoplasmic reticulum (ER) and mitochondria, PON3 abrogates apoptosis in response to DNA damage or intrinsic but not extrinsic stimulation. Moreover, PON3 impaired ER stress-induced apoptotic MAPK signaling and CHOP induction. Therefore, our study reveals the mechanism underlying PON3's anti-oxidative effect and demonstrates a previously unanticipated function in tumor cell development. We suggest PONs represent a novel class of enzymes crucially controlling mitochondrial radical generation and cell death.

AB - To achieve malignancy, cancer cells convert numerous signaling pathways, with evasion from cell death being a characteristic hallmark. The cell death machinery represents an anti-cancer target demanding constant identification of tumor-specific signaling molecules. Control of mitochondrial radical formation, particularly superoxide interconnects cell death signals with appropriate mechanistic execution. Superoxide is potentially damaging, but also triggers mitochondrial cytochrome c release. While paraoxonase (PON) enzymes are known to protect against cardiovascular diseases, recent data revealed that PON2 attenuated mitochondrial radical formation and execution of cell death. Another family member, PON3, is poorly investigated. Using various cell culture systems and knockout mice, here we addressed its potential role in cancer. PON3 is found overexpressed in various human tumors and diminishes mitochondrial superoxide formation. It directly interacts with coenzyme Q10 and presumably acts by sequestering ubisemiquinone, leading to enhanced cell death resistance. Localized to the endoplasmic reticulum (ER) and mitochondria, PON3 abrogates apoptosis in response to DNA damage or intrinsic but not extrinsic stimulation. Moreover, PON3 impaired ER stress-induced apoptotic MAPK signaling and CHOP induction. Therefore, our study reveals the mechanism underlying PON3's anti-oxidative effect and demonstrates a previously unanticipated function in tumor cell development. We suggest PONs represent a novel class of enzymes crucially controlling mitochondrial radical generation and cell death.

KW - apoptosis

KW - cancer

KW - endoplasmic reticulum stress

KW - mitochondria

KW - oxidative stress

KW - paraoxonase

UR - http://www.scopus.com/inward/record.url?scp=84865185479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865185479&partnerID=8YFLogxK

U2 - 10.1038/cdd.2012.35

DO - 10.1038/cdd.2012.35

M3 - Article

C2 - 22441669

AN - SCOPUS:84865185479

VL - 19

SP - 1549

EP - 1560

JO - Cell Death and Differentiation

JF - Cell Death and Differentiation

SN - 1350-9047

IS - 9

ER -